Hajr Eman A, Almuhawas Fida
Department of Ear, Nose and Throat, Imam Mohammad Ibn Saud Islamic University, Riyadh, SAU.
Otolaryngology, King Abdullah Ear Specialist Center, Riyadh, SAU.
Cureus. 2019 Sep 17;11(9):e5684. doi: 10.7759/cureus.5684.
Objective Cochlear implants (CIs) are typically activated four weeks after the implantation surgery. This delay between device implantation and activation lengthens the implant process and consequently induces personal and financial burdens for some patients who travel from remote regions to receive the surgery. However, fitting the speech processor and eliminating the waiting period could decrease the indirect cost associated with cochlear implantation. The objective of this study was to assess the impact of an early CI fitting on the overall cost paid by patients and their families aiming to improve future care strategies for patients receiving CIs. Methods This retrospective study was conducted in a tertiary referral center. All patients who received any kind of CI with early fitting of the speech processor were included. The total financial benefit for the patients and their families over the standard activation visit was investigated by assessing the cost of the non-medical expense for one hospital visit. Results Our results showed that the non-medical cost for each hospital visit associated with cochlear implantation was higher for those who traveled from remote areas: 81 USD for each patient within 200 km of the implantation center and 748.56 USD for each patient farther than 200 km from the implantation center. Conclusions Using the early fitting approach, some of the financial burden associated with implantation could be alleviated.
目的 人工耳蜗(CI)通常在植入手术后四周激活。设备植入与激活之间的这段延迟延长了植入过程,从而给一些从偏远地区前来接受手术的患者带来了个人和经济负担。然而,安装言语处理器并消除等待期可以降低与人工耳蜗植入相关的间接成本。本研究的目的是评估早期人工耳蜗调试对患者及其家庭支付的总费用的影响,旨在改善接受人工耳蜗植入患者的未来护理策略。方法 这项回顾性研究在一家三级转诊中心进行。纳入所有接受任何类型人工耳蜗并早期安装言语处理器的患者。通过评估一次医院就诊的非医疗费用,研究了患者及其家庭相对于标准激活就诊的总经济收益。结果 我们的结果表明,对于来自偏远地区的患者,每次与人工耳蜗植入相关的医院就诊的非医疗费用更高:植入中心200公里范围内的每位患者为81美元,距离植入中心超过200公里的每位患者为748.56美元。结论 使用早期调试方法,可以减轻与植入相关的一些经济负担。